
DSMC adheres to a systematic process, including only those stocks that meet the firm’s proprietary cash-flow-based valuation and quality criteria. DSMC begins with a starting universe of around 1,000 profitable small-and mid-cap U.S stock. Our security selection process eliminates those stocks with high debt levels. We then invest in the most attractively valued remaining 150 companies based on Distillate Capital’s normalized free cash flow methodology. The portfolio is weighted by free cash flow generation and is rebalanced quarterly.
Is DSMC's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

– LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after – – Continued favorable safety profile observed in masked Phase 3 DURAVYU data, consistent with four previously completed clinical trials – – All active patients in the treatment arm have reached their second DURAVYU dosing visit, with over 35% receiving a third dose – WATERTOWN, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that the independent Data Safety Monitoring Committee (DSMC) completed its third scheduled review of the Company's pivotal Phase 3 program evaluating DURAVYU for wet age-related macular degeneration (wet AMD) and recommended that both the LUGANO and LUCIA trials continue as planned with no protocol modifications.

An SEC filing on July 2, 2025, showed Crumly & Associates sold 155,440 shares of Distillate Small/Mid Cash Flow ETF (DSMC 1.82%), totaling $4.98 million in transaction value. After the trade, the fund's remaining stake in Distillate Small/Mid Cash Flow ETF was worth $1.04 million, according to the 13F report.

DSMC is a small/mid-cap cash flow ETF focusing on quality and value factors with unique selection criteria. Its ER is 0.55% and the fund has $104 million in assets. My analysis reveals substantially better quality metrics compared to the Russell 2000 Value ETF almost across the board. DSMC's 12.46x forward P/E is particularly appealing. However, other cash-flow-based ETFs like CALF, SFLO, and SMCF arguably have better fundamentals. DSMC's constituents also have negative earnings growth, which explains why it's lagged YTD.

Investing in stocks with the mindset of a company owner is what's given some of Distillate Capital's best ETFs an edge. The post These ETFs Help You Invest Like An Owner, Not A Speculator appeared first on Investor's Business Daily.

Distillate Capital, a fundamentals-driven equity manager focused on delivering highly differentiated risk-managed value investing strategies, today announced the launch of the Distillate Small/Mid Cash Flow ETF (NYSE Arca: DSMC), the newest addition to the firm's ETF lineup built around the firm's measures of quality, risk, and value as seen through the lens of free cash